LexDanaLexDanabeta
Inventor

Taneisha Ann-Tanara MACK

Inventor
US

Overview

4→
Patents
2021–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07KPeptides36%
A61KPreparations for medical, dental or toiletry purposes18%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
PatentTitleYear
12,497,445Monovalent anti-properdin antibodies and antibody fragments202512,275,798Tri-specific binding molecules202511,802,154Humanized anti-CD200 antibodies and uses thereof202311,198,725Monovalent anti-properdin antibodies and antibody fragments2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2025Patents assigned to ALEXION PHARMA INC (3)· patent assignee history
2021–2025Based in US· patent location history
2025Patents assigned to BOEHRINGER INGELHEIM INT (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ALEXION PHARMA INC32021–2025
BOEHRINGER INGELHEIM INT12025
Locations
LocationPatentsSpan
US42021–2025